Loss of prohibitin 2 in Schwann cells dysregulates key transcription factors controlling developmental myelination

Author:

Wilson Emma R.12ORCID,Nunes Gustavo Della‐Flora13ORCID,Shen Shichen4,Moore Seth1ORCID,Gawron Joseph1,Maxwell Jessica1,Syed Umair1,Hurley Edward1,Lanka Meghana5,Qu Jun4,Désaubry Laurent6,Wrabetz Lawrence17,Poitelon Yannick5ORCID,Feltri M. Laura17

Affiliation:

1. Department of Biochemistry Institute for Myelin and Glia Exploration, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo Buffalo New York USA

2. Department of Clinical Neurosciences University of Cambridge Cambridge England UK

3. Department of Cell and Developmental Biology University of Colorado School of Medicine Aurora Colorado USA

4. Department of Pharmaceutical Sciences State University of New York at Buffalo Buffalo New York USA

5. Department of Neuroscience and Experimental Therapeutics Albany Medical College Albany New York USA

6. Center of Research in Biomedicine of Strasbourg, Regenerative Nanomedicine (UMR 1260), INSERM University of Strasbourg Strasbourg France

7. Department of Neurology Institute for Myelin and Glia Exploration, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo Buffalo New York USA

Abstract

AbstractSchwann cells are critical for the proper development and function of the peripheral nervous system (PNS), where they form a collaborative relationship with axons. Past studies highlighted that a pair of proteins called the prohibitins play major roles in Schwann cell biology. Prohibitins are ubiquitously expressed and versatile proteins. We have previously shown that while prohibitins play a crucial role in Schwann cell mitochondria for long‐term myelin maintenance and axon health, they may also be present at the Schwann cell‐axon interface during development. Here, we expand on this, showing that drug‐mediated modulation of prohibitins in vitro disrupts myelination and confirming that Schwann cell‐specific ablation of prohibitin 2 (Phb2) in vivo results in severe defects in radial sorting and myelination. We show in vivo that Phb2‐null Schwann cells cannot effectively proliferate and the transcription factors EGR2 (KROX20), POU3F1 (OCT6), and POU3F2 (BRN2), necessary for proper Schwann cell maturation, are dysregulated. Schwann cell‐specific deletion of Jun, a transcription factor associated with negative regulation of myelination, confers partial rescue of the developmental defect seen in mice lacking Schwann cell Phb2. Finally, we identify a pool of candidate PHB2 interactors that change their interaction with PHB2 depending on neuronal signals, and thus are potential mediators of PHB2‐associated developmental defects. This work develops our understanding of Schwann cell biology, revealing that Phb2 may modulate the timely expression of transcription factors necessary for proper PNS development, and proposing candidates that may play a role in PHB2‐mediated integration of axon signals in the Schwann cell.

Funder

National Institute of Neurological Disorders and Stroke

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3